Simulations Plus (NASDAQ:SLP) Reaches New 12-Month Low – What’s Next?

Simulations Plus, Inc. (NASDAQ:SLP)’s share price reached a new 52-week low on Friday . The stock traded as low as $24.00 and last traded at $24.96, with a volume of 95166 shares changing hands. The stock had previously closed at $24.68.

Analyst Upgrades and Downgrades

SLP has been the topic of several research reports. KeyCorp lifted their price objective on Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $49.40.

Simulations Plus Stock Up 3.6 %

The company’s fifty day moving average price is $31.29 and its 200-day moving average price is $30.88. The stock has a market capitalization of $513.55 million, a PE ratio of 63.90 and a beta of 0.89.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the transaction, the director now directly owns 3,402,584 shares in the company, valued at $115,381,623.44. The trade was a 0.58 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 19.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Simulations Plus

Hedge funds have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. raised its holdings in Simulations Plus by 82.6% in the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock worth $26,000 after acquiring an additional 370 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock worth $34,000 after acquiring an additional 427 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in Simulations Plus during the 4th quarter valued at $39,000. Quantbot Technologies LP purchased a new stake in Simulations Plus during the 3rd quarter valued at $59,000. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Simulations Plus by 42.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock valued at $72,000 after buying an additional 764 shares during the period. 78.08% of the stock is currently owned by hedge funds and other institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.